Morbidity and Mortality Weekly Report (MMWR)
- Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Also in this issue
January 21, 2022
Disease Surveillance Among U.S.-Bound Immigrants and Refugees — Electronic Disease Notification System, United States, 2014–2019
This report summarizes tuberculosis and other health-related information reported to CDC for refugees, immigrants, and eligible others who arrived in the United States during 2014–2019.
Recommendations and Reports
December 17, 2021
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
ACIP recommends vaccination with Dengvaxia for children aged 9–16 having evidence of previous dengue infection and living in dengue-endemic areas of the U.S.
January 14, 2022
Standards Required for the Development of CDC Evidence-Based Guidelines
CDC presents specific guidelines for the development of evidence-based guidelines that can be trusted by CDC partners and the general public.